In a move that will surprise no one familiar with his questionable career trajectory, Martin Shkreli, the pharmaceutical executive best-known for hiking the price of a lifesaving anti-parasitic drug to $750 from $13.50, has been arrested and charged with securities fraud by the Federal Bureau of Investigation. Read More...